Dr. Kathy Rodgers, Associate Director of Translational Neuroscience, and her research team are investigating a drug that may benefit people with Lou Gehrig’s disease.
https://arizonaalumni.com/arizona-magazine/fall-2022/hope-als-patients
For individuals and families requesting more information about Allo Phase 2 Alzheimer’s Clinical Trial: LEARN MORE
Troubled by hot flashes? Learn more about the HF Relief Study being conducted at the University of Arizona to test the effectiveness of a natural product, PhytoSERM, to alleviate hot flashes: hfrelief.org
For information about the PhytoSERM Brain Clinical Trial: LEARN MORE
Dr. Kathy Rodgers, Associate Director of Translational Neuroscience, and her research team are investigating a drug that may benefit people with Lou Gehrig’s disease.
https://arizonaalumni.com/arizona-magazine/fall-2022/hope-als-patients